Jan 29, 2026 News Releases Generate:Biomedicines Welcomes Aarif Khakoo, MD, MBA, as Chief Scientific Officer Read More
Dec 01, 2025 News Releases Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI Read More
Sep 25, 2025 News Releases Generate:Biomedicines to Present Phase 1 Results for AI-Engineered GB-0895 in Asthma at the European Respiratory Society International Congress Read More
Sep 17, 2025 News Releases Generate:Biomedicines Welcomes Laurie Lee, MD, as Chief Medical Officer for the Immunology & Inflammation Portfolio Read More
Apr 01, 2025 News Releases Generate:Biomedicines Expands Board of Directors with Appointment of Marsha Fanucci Read More
Jan 09, 2025 News Releases Generate:Biomedicines Provides Update on its Platform and Pipeline Powered by AI at the 43rd Annual J.P. Morgan Healthcare Conference Read More
Sep 24, 2024 News Releases Generate:Biomedicines Announces Multi-Target Collaboration with Novartis to Discover and Develop Protein Therapeutics with Generative AI Read More
Jun 13, 2024 News Releases Generate:Biomedicines Expands Board of Directors with the Appointment of Rupert Vessey, M.D., Ph.D., and Nancy Simonian, M.D. Read More
Apr 30, 2024 News Releases Generate:Biomedicines Expands C-suite with Chief Corporate Affairs Officer and Chief Technical Operations Officer Read More